FDA Backs Pfizer COVID-19 Boosters For Seniors, High-Risk

The FDA has approved a third Pfizer booster dose for Americans over 65 and those at high risk of severe disease or exposure at work. The booster must be administered at least six months after the second shot. However, a CDC panel still needs to recommend the booster, and this is not guaranteed.

Who is eligible for the third Pfizer dose according to the FDA?

• Anyone over 70

• Anyone over 65

• Anyone over 60

• Anyone over 50

What is the minimum time gap required between the second shot and the booster for seniors?

• Three months

• Four months

• Six months

• Eight months

Who else can receive the booster shot besides seniors?

• Anyone who wants it

• Only healthcare workers

• Only people with pre-existing conditions

• High-risk individuals or those exposed at work

What must happen before the booster shots can be widely administered?

• The CDC panel must recommend it

• The President must approve it

• The WHO must endorse it

• The FDA must re-evaluate it

Is the CDC panel's recommendation for the booster shots guaranteed?

• Yes, it is guaranteed

• No, it is not guaranteed

• Only if the FDA insists

• Only if the President intervenes